The global Point-Of-Care Testing (POCT) market size reached USD 39.80 Billion in 2021 and is expected to register a revenue CAGR of 10.9% during the forecast period, according to latest analysis by Emergen Research.
The global Point-Of-Care Testing (POCT) market size reached USD 39.80 Billion in 2021 and is expected to register a revenue CAGR of 10.9% during the forecast period, according to latest analysis by Emergen Research. The increasing number of product approvals and launches, the availability of reimbursement policies, and the growing prevalence of chronic diseases are expected to drive the growth of this market. The COVID-19 pandemic has led to a surge in demand for point-of-care diagnostic tests as they offer several advantages over conventional laboratory tests, such as rapid results, portability, and ease of use.
Target diseases continue to evolve, and there is an urgent need for new diagnostic tests that can be used at the point of care. The point-of-care testing market is growing rapidly as a result of the increasing demand for rapid and accurate diagnosis.
A number of individuals in developing countries lack access to quality health care. In many cases, people have to travel long distances to receive basic medical services. This often leads to a delay in diagnosis and treatment, which can be fatal. Point-of-care testing (POCT) is a medical diagnostic test that is performed at the patient’s bedside or near the site of care. This type of testing is generally used to provide quick results, so that patients can receive timely treatment. POCT can be used for a variety of purposes, such as to measure glucose levels in diabetics, to test for infectious diseases, or to monitor the progress of cancer treatment. While POCT has many advantages, there are also some disadvantages, such as the potential for errors and the need for frequent calibrations.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/101
Recent technological advancement in microfluidics and biosensors is playing a vital role in the development of new point of care products. These products are expected to show considerable growth in the near future due to their advantages over traditional methods of diagnosis. However, stringent regulatory policies for approving new point of care products and the lack of standardization are restraining the growth of this market to a certain extent.
Some Key Highlights From the Report
- On the basis of product, the market is categorized into blood glucose testing kits, cholesterol tests, pregnancy & fertility tests, infectious disease tests, cardiac marker tests, urinalysis tests, drug abuse tests, and others. The blood glucose testing kits segment accounted for the largest market share in 2020 owing to the high prevalence of diabetes and the availability of a large number of cost-effective products.
- On the basis of application, the market is classified into cardiology, infectious diseases, oncology, pregnancy & fertility, diabetes, and others. The infectious diseases segment is expected to grow at the fastest CAGR during the forecast period as point-of-care tests offer a quick and convenient way to test for a variety of infections, including influenza, HIV, and tuberculosis.
- On the basis of end use, the market is categorized into hospitals & clinics, home care settings, research laboratories & institutes, and others. The hospitals & clinics segment accounted for the largest market share in 2020 on account of the growing number of point-of-care testing laboratories in these facilities and the increasing number of diagnostic procedures being performed.
- On the basis of region, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the largest market share in 2020 on account of the availability of advanced healthcare infrastructure, the presence of major market players, and the rising prevalence of chronic diseases.
- Some major companies in the global market report include Abbott Laboratories, Quidel Corporation, BD (Becton, Dickinson, and Company), Siemens Healthcare GmbH, Danaher Corporation, Chembio Diagnostics, Inc., Thermo Fisher Scientific Corporation, Nova Biomedical, BioMérieux SA, and Trinity Biotech.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/point-of-care-testing-market
Emergen Research has segmented the global Point-Of-Care Testing (POCT) market on the basis of product, platform, mode of purchase, end-use, and region:
- Product Outlook (Revenue, USD Million; 2019–2030)
- Glucose Monitoring Products
- Strips
- Meters
- Lancets & Lancing Devices
- COVID-19 Testing Products
- Cardiometabolic Monitoring Products
- Cardiac Marker Testing Products
- Blood Gas/Electrolyte Testing Products
- HBA1C Testing Products
- Infectious Disease Testing Products
- HIV Testing Products
- Respiratory Infection Testing Products
- Hepatitis C Testing Products
- Influenza Testing Products
- Others
- Coagulation Monitoring Products
- PT/INR Testing Products
- ACT/APTT Testing Products
- Pregnancy & Fertility Testing Products
- Tumor/Cancer Marker Testing Products
- Drugs-of-Abuse Testing Products
- Other Products
- Glucose Monitoring Products
- Platform Outlook (Revenue, USD Million; 2019–2030)
- Lateral Flow Assays
- Immunoassay
- Molecular Diagnostics
- Dipsticks
- Microfluidics
- Mode of Purchase Outlook (Revenue, USD Million; 2019–2030)
- Over-the-Counter (OTC) Testing Products
- Prescription-Based Testing Products
- End-use Outlook (Revenue, USD Million; 2019–2030)
- Hospital & Critical Care Centers
- Clinical Laboratories
- Home Care & Self Testing
- Ambulatory Care Facilities
- Pharmacies, Retail Clinics & E-commerce Platforms
- Others
- Regional Outlook (Revenue, USD Million; 2018–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/101
Explore More Reports Emergen Research:
Agricultural Lubricants Market
Elder Care Services & Assistive Devices Market
Indoor Farming Technology Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-point-of-care-testing-market